Company / EPS (Basic)
HARROW, INC. EPS (Basic) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.75
FY2025
5-year range
-$0.75 / -$0.51
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#78 of 208
Health Care
What the data says
At $-0.75, HARROW, INC.'s eps (basic) ranks #78 of 208 in the Health Care sector. EPS (Basic) has fluctuated over the past 7 years, ranging from $-0.75 in FY2025 to $0.67 in FY2019.
Based on SEC 10-K filings.
-0.75 in FY2025.
Declined from $-0.51 to $-0.75 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 208 in Health CareTop 37% of 208This company -$0.75 Sector average -$0.96
▼
+22.1% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 0.0% year-over-year.
- Ranks #78 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.75 | +0.0% |
| FY2024 | -$0.75 | -47.1% |
| FY2023 | -$0.51 | +26.1% |
| FY2022 | -$0.69 | - |
| FY2021 | - | - |
| FY2020 | $0.01 | -98.5% |
| FY2019 | $0.67 | +211.7% |
| FY2018 | -$0.60 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026